How to Cite
Downloads
Métricas Alternativas
Dimensions
Abstract
Normal placental development is dependent upon the differentiation and invasion of trophoblast, the main cellular component of the placenta. During this process, trophoblast cells undergo a complex program of differentiation originating several cellular subtypes to ensure the development and progress of human gestation. Trophoblast differentiation is under the control of many autocrine and paracrine factors, that finely tune specific mechanisms that stimulate the expression of a group of genes and increase the production of hormones, including the insulinlike growth factors (IGFs). Certain gestational pathologies are characterized by defective trophoblast differentiaiton and invasion, which is more the result but not the cause of the disease. In this review we will discuss some of the studies focused on the role of the IGF family of growth factors including recent findings in our laboratory and their implications for a better understanding of some gestational diseases. © 2014. Acad. Colomb. Cienc. Ex. Fis. Nat. All rights reserved.References
Alarcón JC. 2011. Interacción del sistema de factores de crecimiento similares a la insulin (IGF) y la hormona gonadotropina coriónica (hGC) en la diferenciación cellular trofoblás-tica. Tesis Maestría Bioquímica. Universidad Nacional de Colombia.Aronow BJ, Richardson BD, Handwerger S. 2001. Microarray analysis of trophoblast differentiation: gene expression reprogramming in key gene function categories. Physiol Genomics. 6 (2): 105-116.
Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R. 2009. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev. 30 (6): 586-623.
Berkowitz RS & Goldstein DP. 1998. Recent advances in gesta-tional trophoblastic disease. Lippincott-Raven Publishers. 10 (1): 61-64.
Bischof P & Irminger-Finger I. 2005. The human cytotrophoblastic cell, a mononuclear chameleon. Int J Biochem Cell Biol. 37:1-6.Bischof P, Meisser A, Campana A. 2001. Biochemistry and Molecular Biology of Trophoblast Invasion. Ann NY Acad Sci, 943 (1): 157-162.
Bruchin I, Werner H. 2013. Targetin IGF-1 signaling pathways in gynecologic malignancies. Expert Opin Ther Targets. 17 (3): 307-320.
Cabezas-Pérez R, Vallejo-Pulido AF, Freyre-Bernal SI, Umaña-Pérez A, Sánchez-Gómez M. 2011. IGF-II y la gonadotropina coriónica regulan la proliferación, migración e invasión de células de trofoblasto humano. Acta Biol Colomb. 16 (1): 143-152.
Carter AM. 2007. Animal models of human placentataion – a review. Placenta. 2 (Suppl A): S41-S47.
Cortés C, Ching R, Páez P, Rodríguez A, León H, Capasso S, Lozano F, González V, Aramendiz H, Pedroza F, Galvis P, Forero E, Aragón M, Arteaga C, Bermúdez AJ. 2003. La mola hidatidiforme: un indicador de la situación sociodemográfica en salud sexual y reproductiva. Inf Quinc Epidemiol Nac. 8 (12): 193-208
Cross JC. 2000. Genetic insights into trophoblast differentiation and placental morphogenesis. Semin Cell Dev Biol. 11: 105-113
Denley A, Cosgrove LJ, Booker GW, Wallace JC, Forbes BE. 2005. CytokineGrowth Factor Rev. 16 (4-5): 421-439.
Díaz LE, Chuan YC, Lewitt M, Fernandez-Perez L, Carrasco-Rodriguez S, Sanchez-Gomez M, Flores-Morales A. 2007. IGF-II regulates metastatic properties of choriocarcinoma cells through the activation of the insulin receptor. Mol Hum Reprod. 13 (8): 567-576.
Díaz, LE. 2006. Niveles de expresión del sistema de factores de crecimiento similares a la insulin (IGFs) en el desarrollo del tejido molar, Tesis Doctorado Química, Universidad Nacional de Colombia.El-Shewy H, Lee M, Obeid L, Jaffa A, Luttrell L. 2007. The insulin-like Growth Factor type 1 and Insulin-like Growth Factor type 2/Mannose-6-phosphate Receptors independently regulate ERK1/2 activity in HEK293 cells. J Biol Chem. 282 (36): 26150-26157.
Ferretti C, Bruni L, Dangles-Marie V, Pecking AP, Bellet D.2007. Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum Reprod Update, 13 (2): 121-141.
Forbes K, Westwood M, Baker PN, Aplin JD. 2008. Insulin like growth factor I and II regulate the life cycle of trophoblast in the developing human placenta. Am J Physiol Cell Physiol. 294 (6): C1313-22.
Frasca F, Pandini G, Sciacca L, Pezzino V, Squatrito S, Belfiore A, Vigneri R. 2008. The role of insulin receptor IGF-I receptors in cancer and other diseases. Arch Physiol Biochem. 114 (1): 23-27.
Freyre SI. 2010. Papel del sistema de factores de crecimiento similares a la insulina (IGF) en la regulación del crecimiento y diferenciación trofoblástica. Tesis Maestría Bioquímica. Universidad Nacional de Colombia.Gallagher EJ, LeRoith D. 2011. Minireview: IGF, insulin and cancer. Endocrinology. 152 (7): 2546-2551.
Ghosh D, Ezashi T, Ostrowski MC, Roberts RM. 2003. A central role for Ets-2 in the transcriptional regulation and cyclic adnosine 5-monophosphate responsiveness of the human chorionic gonadotropin-beta subunit gene. Mol Endocrinol. 17 (1): 11-26
Graham CH, Hawley TS, Hawley RG, MacDougall JR, Kerbel RS, Khoo N, Lala PK. 1993. Establishment and Characterization of First Trimester Human Trophoblast Cells with Extended Lifespan. Exp Cell Res. 206 (2): 204-211.
Graham CH & Lala PK. 1992. Mechanisms of placental invasion of the uterus and their control. Biochem Cell Biol, 70 (10-11): 867-874.
Han VK, Carter AM. 2000. Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. Placenta. 21 (4): 289-305.
Hanahan D & Weinberg RA. 2000. The hallmarks of cancer. Cell. 100:57-70.
Handwerger S. 2010. New insights into de human cytotrophoblast differentiation. Mol Cell Endocrinol. 323: 94-104.
Huppertz B, Bartz C, Kokozidou. 2007. Trophoblast fusión: fusogenic proteins, syncytins and ADAMs, and other prerequisites for syncytial fusion. Micron. 37 (6): 509-517.
Johnson W & Jameson JL. 2000. Role of Ets2 in cyclic AMP regulation of the human chorionic gonadotropin (beta) promoter. Mol Cell Endocrinol. 165 (1-2):17-24.
Kemp B, Kertschanska S, Kadyrov M, Rath W, Kaufmann P, Hupperz B. 2002. Invasive depth of extravillous trophoblast correlates with cellular phenotype: A comparison of intra- and extra-uterine implantation sites. Histochem Cell Biol. 117: 401-414.
Kimura AP, Sizova D, Handwerger S, Cooke NE, Liebhaber SA. 2007. Epigenetic activation of the human growth hormone gene cluster during placental cytotrophoblast differentiation. Mol Cell Biol. 27: 6555-6568.
Kliman, HJ and Feinberg RF. 1990. Human trophoblast-extracellular matrix (ECM) interactions in vitro: ECM thickness modulates morphology and proteolytic activity. Proc Natl Acad Sci U S A, 87 (8): 3057-3061.
Kreiling J, Byrds J, MacDonald R. 2005. Domain Interactions of the Mannose 6-Phosphate/Insuline-like Growth Factor II Receptor. J Biol Chem. 280 (22): 21067-21077.
Lala P.K, Hamilton GS, Athanassiades A. 1998. Role of growth factors and other placental signals in extravillous trophoblast cell function: A review. Placenta. 19: 327-339.
LeRoith D & Roberts C. 2003. The insulin-like growth factor system and cancer. Cancer Letters. 195 (2):127-137.
LeRoith D, Werner H, Neuenschwander S, Kalebic T & Helman LJ. 1995. The role of the insulin-like growth factor-I receptor in cancer. Ann NY Acad Sci. 766: 402-406.
McKinnon T, Chakraborty C, Gleeson LM, Chidlac P, Lala PK. 2001. Stimulation of Human Extravillous Trophoblast Migration by IGF-II Is Mediated by IGF Type 2 Receptor Involving Inhibitory G Protein(s) and Phosphorylation of MAPK. J Clin Endocrinol Metab. 86 (8): 3665-3674.
Murphy SK, Huang Z, Wen Y, Spillman MA, Whitaker RS, Simel LR, Nichols TD, Marks JR, Berchuck A. 2006. Frequent IGF2/H19 doamin epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer. Mol Cancer Res. 4 (4): 283-292.
Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R, Belfiore A. 2002. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem. 277 (42): 39684-39695.
Pavelic K, Bukovic D, Pavelic J. 2002. The role of insulin-like growth factor 2 and its receptors in human tumors. Mol Med. 8 (12): 771-780.
Pinzón ML, Ortiz BL, Sánchez de Gómez M. 2007. Relación de la expression de mARN de las metaloproteinasas 2 y 9 y el inhibidor TIMP-1 en mola hidatidiforme completa. Rev Col Quim. 36 (2) 137-149.
Samani AA, Yakar S, LeRoith D, Brodt P. 2007. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev. 28 (1): 20-47.
Sánchez de Gómez M. 2006. Significado biológico del eje hormona de crecimiento (GH) / Factor de crecimiento similar a la insulin (IGF). Rev Acad Colomb Cienc. 30 (114): 101-108.
Scott IC, Anson-Cartwright L, Riley P, Reda D, Cross JC. 2000. The Hand1 basic helix-loop-helix transcription factor regulates trophoblast differentiation in a multiple mechanisms. Mol Cell Biol. 20, 530-541.
Seckl MJ, Fisher RA, Salerno G, Rees H, Paradinas FJ, Foskett M, Newlandas ES. 2000. Choriocarcinoma and partial hydatidiform moles. Lancet. 356 (9223): 36-39.
Singh P, Alex JM, Bast F. 2014. Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies. Med Oncol. 31 (1): 805.
Silva C, Kloth M, Lyons C, Dunn C. and Kirk S. 2002. Intracellular signaling by growth hormone variant (GH-V). Growth Hormone & IGF Research, 12: 374-380.
Staun-Ram E, Goldman S, Gabarin D and Shaley E. 2004. Expression and importance of matrix metalloprot 2 and 9 (MMP-2 and -9) in human trophoblast invasion. Reprod Biol Endocrinol. 2 (1): 59
Vallejo AF, Flores-Morales A, Norstedt G, Sanchez-Gomez M. 2014. Down-regulation of Insulin-like growth factor I receptor and Insulin receptor by siRNA reduce the invasiveness of trophoblast cells: Role of MMP-9. To be submitted.
Vallejo AF. 2011. Importancia de los receptors híbridos receptor de insulina/receptor del factor de crecimiento similar a la insulin tipo I (InsR/IGF-IR) en las redes de señalización del sistema IGF. Tesis Doctorado Química, Universidad Nacional de Colombia.Yang M, Lei ZM & Rao Ch V. 2003. The central role of human chorionic gonadotropin in the formation of human placental syncytium. Endocrinol, 144: 1108-1120.
Zygmunt M, McKinnon T, Herr F, Lala PK, Han VK. 2005. HCG increases trophoblast migration in vitro via the insulin-like growth factor-II/mannose-6 phosphate receptor. Mol. Hum. Reprod. 11 (4): 261-267.
Declaration of originality and transfer author's rights
The authors declare:
- The published data and reference materials have been duly identified with their respective credits and have been included in the bibliographic notes and citations that have been so identified and that should it be required, I have all releases and permissions from any copyrighted material.
- All material presented is free from any copyright and that I accept full legal responsibility for any legal claims relating to copyrighted intellectual property, fully exonerating from responsibility the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales.
- This work is unpublished and will not be sent to any other journal while waiting for the editorial decision of this journal. I declare that there is no conflict of interest in this manuscript.
- In case of publication of this article, all author´s rights are transferred to the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales, and so cannot be reproduced in any form without the express permission of it.
- By means of this document, if the article is accepted for publication by the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales, the Revista assumes the right to edit and publish the articles in national and international indices or data bases for academic and scientific use in paper, electronic, CD-ROM, internet form either of the complete text or any other known form known or to be known and non-commercial, respecting the rights of the authors.
Transfer of author rights
In case the article is approved for publication, the main author in representation of himself and his co-authors or the main author and his co-authors must cede the author rights of the corresponding article to the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales, except in the following cases:
The authors and co-authors will retain the right to revise, adapt, prepare derived works, oral presentations, and distribution to some colleagues of reprints of their own published work, if the corresponding credit is given to the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales. It is also permissible to publish the title of the work, summary, tables, and figures of the work in the corresponding web sites of the authors or their employers, also giving credit to the Revista.
If the work has been realized under contract, the author’s employer has the right to revise, adapt, prepare derivative works, reproduce, or distribute in hard copy the published work, in a secure manner and for the exclusive use of his employees.
If the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales were approached for permission by a third party for using, printing, or publishing specifically articles already published, the Revista must obtain the express permission of the author and co-authors of the work or of the employer except for use in classrooms, libraries, or reprinted in a collective work. The Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales reserves the possible use in its front cover of figures submitted with the manuscripts.
No other right, other than the author’s right, can be claimed by the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales.